ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis

The objective of this non-interventional study (NIS) is to gain comprehensive insights into the practicability of ADL-PDT with Metvix® in patients with actinic keratoses under real-world conditions.

Inclusion Criteria:Written informed consent to participate in the studyAge ≥18 yearsThin or non-hyperkeratotic and non-pigmented actinic keratoses (AK) on the face or scalp (Olsen grade 1 or Olsen grade 2)The decision to undergo ADL-PDT with Metvix® was made independently of this studyNo contraindication (according to the SmPC)Exclusion Criteria:Hypersensitivity to the active substance or to one of the other ingredients listed in section 6.1 of the SmPC or other ingredients, including peanut oil, peanut or soy.Morphaeaform basal cell carcinomaPorphyriaPregnancy